Prognostic evaluation of interim PET negative DLBCL patients: Can baseline and interim PET imaging with clinical indicators offer additional value?

被引:0
|
作者
Chen, Xi [1 ]
Sun, Xun [1 ,2 ]
Zhang, Yongxue [1 ]
An, Rui [3 ]
Lan, Xiaoli [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Nucl Med, Wuhan, Peoples R China
[2] Hubei Key Lab Mol Imaging, Wuhan, Peoples R China
[3] HUST, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
241610
引用
收藏
页数:3
相关论文
共 50 条
  • [1] The Prognostic Value of Interim PET Scan in Patients with Classical Hodgkin Lymphoma
    Oki, Yasuhiro
    Chuang, Hubert
    Chasen, Beth
    Pan, Tinsu
    Fanale, Michelle A.
    Dabaja, Bouthaina S.
    Fowler, Nathan H.
    Romaguera, Jorge Enrique E.
    Fayad, Luis E.
    Hagemeister, Fredrick B.
    Rodriguez, Alma
    Neelapu, Sattva S.
    Samaniego, Felipe
    Kwak, Larry W.
    Younes, Anas
    BLOOD, 2012, 120 (21)
  • [2] Improved Risk Prediction in DLBCL By Combining Clinical and PET Features with Interim PET Assessment
    Hanoun, Christine
    Heymans, Martijn
    Wiegers, Sanne
    Bes, Annelies
    Duehrsen, Ulrich
    Huettmann, Andreas
    Kurch, Lars
    Barrington, Sally F.
    Mikhaeel, George
    Lugtenburg, Pieternella
    Ceriani, Luca
    Zucca, Emanuele
    Gyorke, Tamas
    Czibor, Sandor
    Zwezerijnen, Gerben
    Boellaard, Ronald
    Zijlstra, Josee M.
    Eertink, Corinne
    BLOOD, 2023, 142
  • [3] THE PROGNOSTIC VALUE OF INTERIM 18 FDG PET IN LYMPHOMA
    Dobson, R.
    Bartholomeusz, D.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 38 - 38
  • [4] Prognostic value of interim 18F-FDG PET/CT in DLBCL according to molecular profiles
    Kim, J.
    Song, Y.
    Kim, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S312 - S312
  • [5] Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL
    Macaulay, Charles
    Alig, Stefan
    Kurtz, David M.
    Jin, Michael C.
    Opat, Stephen
    Soo, Joanne
    Sworder, Brian
    Hertzberg, Mark S.
    Gandhi, Maher K.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2019, 134
  • [6] Prognostic value of interim PET in aggressive non Hodgkin lymphoma
    Aloj, Luigi
    Frigeri, Ferdinando
    Caraco, Corradina
    Mettivier, Laura
    Capobianco, Gaetana
    Volzone, Francesco
    Morisco, Anna
    Ibello, Francesco
    Pinto, Antonio
    Lastoria, Secondo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [7] FDG-PET in aggressive non Hodgkin lymphoma: the prognostic value of interim evaluation
    Aloj, L.
    Frigeri, F.
    Caraco, C.
    Crisci, S.
    Farese, R.
    Ibello, F.
    Morisco, A.
    Capobianco, G.
    Volzone, F.
    Pinto, A.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S692 - S692
  • [8] Interim (18)F-FDG PET prognostic value in Hodgkin lymphoma patients
    Kirienko, Margarita
    Guerra, Luca
    Bolis, Silvia
    Sassone, Marianna
    De Ponti, Elena
    Messa, Cristina
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
    Eertink, J. J.
    Burggraaff, C. N.
    Heymans, M. W.
    Duehrsen, U.
    Huettmann, A.
    Schmitz, C.
    Mueller, S.
    Lugtenburg, P. J.
    Barrington, S. F.
    Mikhaeel, N. G.
    Carr, R.
    Czibor, S.
    Gyoerke, T.
    Ceriani, L.
    Zucca, E.
    Hutchings, M.
    Kostakoglu, L.
    Loft, A.
    Fanti, S.
    Wiegers, S. E.
    Pieplenbosch, S.
    Boellaard, R.
    Hoekstra, O. S.
    Zijlstra, J. M.
    de Vet, H. C. W.
    BLOOD ADVANCES, 2021, 5 (09) : 2375 - 2384
  • [10] Prognostic value of interim PET/CT in non-hodgkin lymphoma
    Ladron de Guevara, David
    Bernard, Sebastian
    Manhood, Susana
    Melani, Sophia
    Yerovi, Fernando
    de los Angeles Rodriguez, Maria
    REVISTA MEDICA DE CHILE, 2020, 148 (11) : 1558 - 1567